rs121918104
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000394936.8(PSAP):āc.722G>Cā(p.Cys241Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000137 in 1,460,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C241G) has been classified as Pathogenic.
Frequency
Consequence
ENST00000394936.8 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSAP | NM_002778.4 | c.722G>C | p.Cys241Ser | missense_variant, splice_region_variant | 7/14 | ENST00000394936.8 | NP_002769.1 | |
PSAP | NM_001042465.3 | c.722G>C | p.Cys241Ser | missense_variant, splice_region_variant | 7/15 | NP_001035930.1 | ||
PSAP | NM_001042466.3 | c.722G>C | p.Cys241Ser | missense_variant, splice_region_variant | 7/15 | NP_001035931.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSAP | ENST00000394936.8 | c.722G>C | p.Cys241Ser | missense_variant, splice_region_variant | 7/14 | 1 | NM_002778.4 | ENSP00000378394 | P1 | |
PSAP | ENST00000633965.1 | c.125G>C | p.Cys42Ser | missense_variant, splice_region_variant | 2/6 | 5 | ENSP00000488331 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460600Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726722
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Sphingolipid activator protein 1 deficiency Pathogenic:4
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Sep 26, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 17, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Pathology and Clinical Laboratory Medicine, King Fahad Medical City | - | Enzyme deficiency - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 25, 1991 | - - |
Combined PSAP deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jun 26, 2017 | PVS1: Homozygous variant reported in 9 patients from 4 Arab families, likely Founder mutation (PMID: 17878207). PM2: Absent from gnomAD. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 19, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Parkinson disease 24, autosomal dominant, susceptibility to Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 21, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at